Stocks-BNTX-BioNTech SE-ADR

BNTX BioNTech SE-ADR

139.97 -0.51 (-0.36%)
Delayed Prices By NASDAQ, in USD Market Open
Invest
Invest

Overview

Prev Close140.49
Day's Range 137.80 - 142.79
52 Week Range 117.21 - 188.56
Average Volume (3M)955.35K
1-Year Return-18.14%
Beta0.8071
Market Cap34.09B
P/E Ratio3.01
Revenue20.36B
EPS46.7335
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.717/08/202228/10/202211/01/2023120.00130.00140.00150.00160.00170.00180.00190.00
Chart times in UTC
Industry Biotechnology
CEO Ugur Sahin, MD
Employees 3,082

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: BioNTech SE-ADR's revenues increased by 3,979.40% and amounted to 22.43B. Net income increased by 70,118.22% to 12.17B. Net assets increased by 705.80% to 13.53B and EPS increased from 0.07 to 46.84.
BNTX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
81.88%
Net Profit Margin
-36.29%
Operating Margin
72.05%
Return On Investment
10.58%
12/21
03/22
06/22
09/22
Total Revenue
6.32B
7.15B
3.4B
3.48B
Gross Profit
5.66B
5.7B
2.59B
2.73B
Operating Income
5.18B
5.26B
2.01B
2.23B
Net Income
3.62B
4.15B
1.78B
1.8B